A common New Year’s resolution is to pay more attention to your health and now there’s a new procedure to assist men to monitor a serious health issue and potentially avoid major surgery. The Lovelace ...

More than 50% of men over the age of 50 suffer from benign prostatic hyperplasia, also known as an enlarged prostate. While BPH is common for older men, causing the frequent urge to urinate — ...

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the Interventional Urology Business Unit has released new clinical data across two major ...

Teleflex announces favorable results for UroLift™ in treating BPH, showing higher patient satisfaction and better early recovery compared to Rezūm. Teleflex Incorporated announced new results from the ...

Physician brings non-surgical outpatient prostate procedure to McLaren Northern Michigan, providing quicker recovery times. Featured in the 2021 issue of MyNorth Medical Insider. When Bryan Shumaker, ...

Teleflex TFX recently announced the upcoming full market release of the Advanced Tissue Control (“ATC”) feature on its unified UroLift 2 System — a platformdesigned for the treatment of benign ...

The Texas Urological Clinic has been named a UroLift Center of Excellence for its work performing the UroLift procedure. The procedure is a new approach to treating BPH or enlarged prostate, Dr. Shawn ...

Highlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia (BPH) - Additional studies examine ...

WAYNE, Pa., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX) (NYSE:TFX), a leading global provider of medical technologies, announced today that a new peer-reviewed study in the Nature ...

Teleflex Inc. received favorable results for a multi-center study reaffirming the safety and effectiveness of its UroLift System. The Wayne, PA-based company said the results were published in the ...